The experimental results showed that compared with the control cell lines, the ccRCC cell lines with stable knockdown of NUDT1 has a faster rate of decrease in cell viability against the same sunitinib concentration (Figure S14A). Here, NUDT1 is linked to nonpapillary renal cell carcinoma.